EMG Biosensors Market Trends

Growth Drivers

Growing Geriatric Population Across the Globe - Elderly people are more prone to neuromuscular diseases such as sarcopenia, and the rising number of elderly populations around the globe is estimated to drive market growth. Besides this, elderly people often need physical therapy in which EMG biosensors help in providing real-time feedback and monitoring the progress. According to estimates, the number of individuals in the world who are 60 or older will rise to over 2 billion by 2050.
Surging Popularity of Minimally Invasive Surgery - The EMG treatment is non-invasive, and its non-invasive nature and practicality are thought to be the key drivers of its widespread implementation. EMG data are collected primarily via the non-invasive technique of skin surface sampling.
Rising Demand for Wearable Devices - Wearable technology offers an alternative to clinical diagnostics with minimal invasiveness and can be used to track mental health, offer early diagnosis, and perform guided training.
Increasing Prevalence of Neurological Diseases - Medical professionals frequently employ EMG instruments for the early diagnosis of neurological disorders and are being investigated more and more as assessment tools for impairment in neurological diseases. Moreover, Parkinson's disease one of the most significant in terms of the future global burden of diseases can be identified by EMG, and can also be used to track the effectiveness of treatment. For instance, neurological illnesses make up over 7% of the global incidence of illness.

Challenges

Exorbitant Cost of EMG Biosensors - EMG biosensors include sensitive electrodes, amplifiers, and other advanced technology that necessitate substantial research and development, which raises the overall production costs. Besides this, the cost and difficulty of acquiring invasive electromyography and surface electromyography (sEMG) are high since they consume a lot of power.
Inaccurate Data Can Lead to Incorrect Diagnosis and Misinterpretation
Lack of Standardization and Regulation May Restrict Entry for New EMG Biosensor Technologies
Privacy and Data Security Concerns

EMG Biosensors Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	~9%
Base Year Market Size (2023)	~ USD 625 Million
Forecast Year Market Size (2036)	~ USD 2 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

Increasing cases of musculoskeletal disorders and the growing technological advancements in EMG biosensors are the major factors driving the growth of the market.

The market size of EMG biosensors is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2024-2036.

The major players in the market are OpenBCI Inc., Multi Biosensors Inc., Innopsys Inc., Biometrics Ltd., Butler Technologies, Inc., mDurance Solutions SL., iMotions A/S, Delsys Incorporated, Pinnacle Technology, and others.

The hospitals and clinics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

EMG Biosensors Market Trends